4D Molecular Therapeutics FDMT
NASDAQ FDMT
$14.49 -0.07 (-0.48%)
At close: Sep 29, 2026 · 4:00 PM EDT

4D Molecular Therapeutics (FDMT) Operating Margin (2020 - 2026)

Updated

4D Molecular Therapeutics (FDMT) reported Operating Margin of -2037.16% for Q2 2026, up 394336.17 percentage points from -396373.33% a year earlier and up 378.99 percentage points from the prior quarter.

Analysis

4D Molecular Therapeutics (FDMT) Operating Margin (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, 4D Molecular Therapeutics' Operating Margin came in at -214.24%, up 667440.31 percentage points year-over-year; for FY2025, it was -187.24%, up 507491.14 percentage points from FY2024.

  • Operating Margin has a five-year change of +229.04 percentage points (FY2020 to FY2025).
  • By year, Operating Margin came in at -507678.38% in FY2024 (-507133.73 pp), -544.65% in FY2023 (+2971.88 pp), -3516.52% in FY2022 (-3121.06 pp) and -395.46% in FY2021 (+20.82 pp).
  • Five-year quarterly Operating Margin spans a low of -5611700.00% in Q4 2024 and a high of 17.29% in Q4 2025.
  • Year over year, Operating Margin has now increased in each of the last five quarters, with an average year-over-year change of +932095.69 percentage points over the last seven quarters.
  • The high point for year-over-year Operating Margin in five years was Q4 2025 (a gain of 5611717.29 percentage points); the low point was Q3 2024 (a drop of 1704330.84 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -2416.15% (Q1 2026), 17.29% (Q4 2025) and -67983.33% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 4D Molecular Therapeutics 1.02 Bn -436.78 Mn - -2,037.16%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,037.16%
Mar 31, 2026 -2,416.15%
Dec 31, 2025 17.29%
Sep 30, 2025 -67,983.33%
Jun 30, 2025 -396,373.33%
Mar 31, 2025 -383,007.14%
Dec 31, 2024 -5,611,700.00%
Sep 30, 2024 -1,704,400.00%
Jun 30, 2024 -849,120.00%
Mar 31, 2024 -136,200.00%
Sep 30, 2023 -69.16%
Jun 30, 2023 -13,446.03%
Mar 31, 2023 -10,102.68%
Dec 31, 2022 -2,303.13%
Sep 30, 2022 -5,299.00%
Jun 30, 2022 -17,546.91%
Mar 31, 2022 -2,165.05%
Dec 31, 2021 -26,917.39%
Sep 30, 2021 -1,658.93%
Jun 30, 2021 -52.10%
API Access

4D Molecular Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=FDMT&period=max&api_key=YOUR_API_KEY